The European Society for Hemapheresis - short ESFH - was founded in 1984 with the aim of gathering European physicians, scientists, and allied health personnel working in the field of Hemapheresis with a vision to improve donor and patient care. The mission of ESFH is to advance knowledge in apheresis techniques through education, to consolidate and spread proven methods, and to open new paths in the collection of blood cells and treatment of diseases by apheresis.

Learn More

From the literature:


Upcoming Webinar:Thursday, June 6th , 2024 ;  3 pm CET
Challenging Apheresis Procedures for Neuroimmune Disorders.....
Link for Registration
Download Folder


  • Therapeutic Approaches to Sickle Cell Disease,
      September 21, 2023
  • Therp announs sept 2023

  •  CAR-T with twoexperts from the Hospital Clínic of Barcelona in Spain,  
    Wednesday, February 22, 2023,  3 pm to 4:30 pm (GMT+1)

M.Lozano  Mononuclear cell collection for CAR-T therapies
Dr. Miquel Lozano 

Novel applications of CAR-T therapies
Dr. Julio Delgado



Previous ESFH Congresses

 held as ahybrid joint meeting of theTurkish Hematology Society, WAA and ESFH
2022 September 14th – 17th
Istanbul, Turkey

ESFH 21th Congress
2021,May 26th - 27th Digital (rescheduled)

ESFH 20th Congress  2018
13th/14th June 2018 Hospital La Fe, Valencia, Spain

 WebinarHow to optimize blood transfusion treatment outcomes for SCD patients?”


Recently an interesting investigation was published in Vox Sanguinis concerning in vitro evaluation of buffy coat derived granulocytes for the...
In this paper, the group from Pamplona shows data of stem cell mobilization with filgrastim (G-CSF) in 36 healthy family donors, of which 18...
In this paper the authors reviewed more than 50.000 extracorporeal procedures in 7.142 patients regarding incidence and severity of apheresis...